The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, tolerability, pharmacokinetics and clinical activity of AST-3424, an AKR1C3-activated bis-alkylating moiety prodrug, in subjects with advanced solid tumors in China: A phase I dose-escalation study.
 
Shukui Qin
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Suxia Luo
Consulting or Advisory Role - KYM Biosciences
 
Ying Jieer
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Qichun Cai
No Relationships to Disclose
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - GlaxoSmithKline; Merck Serono; MSD; Roche
 
Junli Xue
No Relationships to Disclose
 
Zan Teng
No Relationships to Disclose
 
Jiawei Shou
No Relationships to Disclose
 
Yanbin Xie
Employment - Ascentawits Pharmaceutical
 
Jianxin Duan
Employment - Ascentawits Pharmaceutical
 
Ning Wang
Employment - Ascentawits Pharmaceutical
 
Qiuyue Shan
Employment - Ascentawits Pharmaceutical
 
Qian Zhu
Employment - Ascentawits Pharmaceutical
 
Ye Li
Employment - Ascentawits Pharmaceutical
 
Nan Liu
Employment - Ascentawits Pharmaceuticals, Ltd
Honoraria - Ascentawits Pharmaceuticals, Ltd
 
Lin Sun
Employment - Ascentawits Pharmaceutical
 
Jing Hao
Employment - Ascentawits Pharmaceutical